Literature DB >> 25192511

The urea cycle disorders.

Guy Helman1, Ileana Pacheco-Colón2, Andrea L Gropman1.   

Abstract

The urea cycle is the primary nitrogen-disposal pathway in humans. It requires the coordinated function of six enzymes and two mitochondrial transporters to catalyze the conversion of a molecule of ammonia, the α-nitrogen of aspartate, and bicarbonate into urea. Whereas ammonia is toxic, urea is relatively inert, soluble in water, and readily excreted by the kidney in the urine. Accumulation of ammonia and other toxic intermediates of the cycle lead to predominantly neurologic sequelae. The disorders may present at any age from the neonatal period to adulthood, with the more severely affected patients presenting earlier in life. Patients are at risk for metabolic decompensation throughout life, often triggered by illness, fasting, surgery and postoperative states, peripartum, stress, and increased exogenous protein load. Here the authors address neurologic presentations of ornithine transcarbamylase deficiency in detail, the most common of the urea cycle disorders, neuropathology, neurophysiology, and our studies in neuroimaging. Special attention to late-onset presentations is given. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25192511     DOI: 10.1055/s-0034-1386771

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  14 in total

1.  Hepatic arginase deficiency fosters dysmyelination during postnatal CNS development.

Authors:  Xiao-Bo Liu; Jillian R Haney; Gloria Cantero; Jenna R Lambert; Marcos Otero-Garcia; Brian Truong; Andrea Gropman; Inma Cobos; Stephen D Cederbaum; Gerald S Lipshutz
Journal:  JCI Insight       Date:  2019-09-05

2.  Impact of immobilization technology in industrial and pharmaceutical applications.

Authors:  Mohamed E Hassan; Qingyu Yang; Zhigang Xiao; Lu Liu; Na Wang; Xiaotong Cui; Liu Yang
Journal:  3 Biotech       Date:  2019-11-08       Impact factor: 2.406

3.  Arginase I mRNA therapy - a novel approach to rescue arginase 1 enzyme deficiency.

Authors:  Kirtika H Asrani; Lei Cheng; Christopher J Cheng; Romesh R Subramanian
Journal:  RNA Biol       Date:  2018-07-24       Impact factor: 4.652

4.  Features of Adult Hyperammonemia Not Due to Liver Failure in the ICU.

Authors:  Amra Sakusic; Moldovan Sabov; Amanda J McCambridge; Alejandro A Rabinstein; Tarun D Singh; Kumar Mukesh; Kianoush B Kashani; David Cook; Ognjen Gajic
Journal:  Crit Care Med       Date:  2018-09       Impact factor: 7.598

Review 5.  Fifteen years of urea cycle disorders brain research: Looking back, looking forward.

Authors:  Kuntal Sen; Matthew Whitehead; Carlos Castillo Pinto; Ljubica Caldovic; Andrea Gropman
Journal:  Anal Biochem       Date:  2021-10-09       Impact factor: 3.365

Review 6.  Liver-humanized mice: A translational strategy to study metabolic disorders.

Authors:  Yonghong Luo; Haocheng Lu; Daoquan Peng; Xiangbo Ruan; Yuqing Eugene Chen; Yanhong Guo
Journal:  J Cell Physiol       Date:  2021-10-18       Impact factor: 6.513

7.  Rescue of the Functional Alterations of Motor Cortical Circuits in Arginase Deficiency by Neonatal Gene Therapy.

Authors:  Gloria Cantero; Xiao-Bo Liu; Ronald F Mervis; Maria T Lazaro; Stephen D Cederbaum; Peyman Golshani; Gerald S Lipshutz
Journal:  J Neurosci       Date:  2016-06-22       Impact factor: 6.167

8.  Ornithine transcarbamylase downregulation is associated with poor prognosis in hepatocellular carcinoma.

Authors:  Lin He; Xuefei Cai; Shengtao Cheng; Hongzhong Zhou; Zhenzhen Zhang; Jihua Ren; Fang Ren; Qiuxia Yang; Nana Tao; Juan Chen
Journal:  Oncol Lett       Date:  2019-03-21       Impact factor: 2.967

9.  Ammonia induces calpain-dependent cleavage of CRMP-2 during neurite degeneration in primary cultured neurons.

Authors:  Zhenbin Cai; Xiaonan Zhu; Guowei Zhang; Fengming Wu; Hongsheng Lin; Minghui Tan
Journal:  Aging (Albany NY)       Date:  2019-07-06       Impact factor: 5.682

10.  Clinical and genetic analysis of five Chinese patients with urea cycle disorders.

Authors:  Zhenzhu Zheng; Yiming Lin; Weihua Lin; Lin Zhu; Mengyi Jiang; Wenjun Wang; Qingliu Fu
Journal:  Mol Genet Genomic Med       Date:  2020-05-15       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.